Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Inspire Medical Systems, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-43.3% vs price
Base Case (Median)
8.0% vs price
Bull Case (75th pct.)
52.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $100.24 | 58.9% | Medium (25%) |
| Growth Trajectory DCF | $249.70 | 295.9% | Medium (20%) |
| Graham Number | $52.55 | -16.7% | Medium (40%) |
| EV/EBITDA | $30.19 | -52.1% | Medium (20%) |
| EV/FCF | $83.73 | 32.8% | Medium (20%) |
| Earnings Power Value | $1.11 | -98.2% | Medium (50%) |
Based on 6 out of 8 methods, INSP appears fairly valued at the current price of $63.07. The base case fair value of $68.14 implies 8.0% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.